Alzheimer’s – Arkansas News Network

Families in the capital city honor loved ones with Walk to End Alzheimer’s

admin6 months ago05 mins

On November 10, 2024, families in the capital city united for the Walk to End Alzheimer’s, honoring their loved ones and raising vital funds for research and support. Nearly 60,000 Arkansans live with Alzheimer’s or dementia, supported by over 150,000 caregivers facing immense emotional and financial challenges. The event drew participants from across New York City, who were motivated by a shared determination to combat this devastating disease. Each walker carried a flower, representing their commitment to finding a cure and improving lives affected by dementia.

Newark native named Volunteer of the Year by Alzheimer’s Arkansas

admin9 months ago01 mins

Every year, thousands of volunteers dedicate their time and energy to helping those affected by Alzheimer’s disease. One such dedicated individual was recently named the Volunteer of the Year by Alzheimer’s Arkansas.

Possible Dementia, Alzheimer’s Breakthrough Treatment Discovered by UAMS Researchers

admin9 months ago03 mins

A groundbreaking development in Alzheimer’s research has been unveiled by the University of Arkansas for Medical Sciences (UAMS), led by Dr. Sue Griffin. Their focus on preventing the disease, rather than treating symptoms, has led to the discovery of a potential drug candidate known as CBA2 targeting the ApoE4 protein. With funding from the National Institutes of Health, the team is making strides towards combating Alzheimer’s and offering hope to those at risk.

UAMS researchers discover cholesterol drug’s potential as treatment for Alzheimer’s, other dementia

admin9 months ago03 mins

A groundbreaking discovery by UAMS researchers reveals the potential of the cholesterol drug ezetimibe in treating Alzheimer’s disease and other forms of dementia. The drug has been shown to significantly lower the risk of developing Alzheimer’s, focusing on the aggregates of tangled proteins found in the brains of patients. Through advanced 3D-analysis tools, the researchers pinpointed ezetimibe’s ability to prevent specific proteins from sticking together, potentially providing a new intervention for high-risk groups. This breakthrough offers hope for disrupting the progression of Alzheimer’s and related cognitive disorders.

UAMS researchers identify cholesterol medication as potential Alzheimer’s treatment

admin9 months ago03 mins

Researchers at the University of Arkansas for Medical Sciences (UAMS) have made a significant breakthrough in the search for Alzheimer’s treatments, suggesting that a commonly used cholesterol medication might hold the key to halting the progression of this debilitating disease and other forms of dementia. By repurposing this FDA-approved drug, UAMS scientists have discovered a promising path towards tackling Alzheimer’s, with the potential to slow or even halt cognitive decline in patients. The correlation between high cholesterol levels and Alzheimer’s development has raised interest in lipid-lowering agents, and the UAMS research sheds new light on the benefits of cholesterol medications in addressing this disease. This groundbreaking study highlights the ongoing efforts within the medical community to explore novel treatments for Alzheimer’s, offering hope to those affected and their families.

UAMS researchers identify cholesterol medication as potential Alzheimer’s treatment

admin9 months ago05 mins

The discovery of ezetimibe’s potential as an Alzheimer’s treatment marks a significant breakthrough in the fight against this devastating disease. With promising results from initial studies, researchers are hopeful that this cholesterol medication could offer new hope to millions of individuals affected by Alzheimer’s and related dementias. As further clinical trials are planned to assess ezetimibe’s efficacy in preventing cognitive decline, the future of Alzheimer’s care appears brighter than ever. This research paves the way for new possibilities in the treatment and prevention of Alzheimer’s, offering a glimmer of hope to those impacted by this challenging condition.